Ушбу ишга иқтибос қилган ишлар

2 та иш

Иш: HER2 CAR-T Cells Eradicate Uveal Melanoma and T-cell Therapy–Resistant Human Melanoma in IL2 Transgenic NOD/SCID IL2 Receptor Knockout Mice

1. Immuno-oncology approaches to overcome T cell exhaustion in melanoma

   Amr Ali Mohamed Abdelgawwad El‐Sehrawy, Mohammad Y. Alshahrani, Muzdalifa Mejbel Fedwi +7

   МақолаCancer Immunotherapy and BiomarkersSeminars in Oncology20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.article.010728

2. Checkpoint inhibition and beyond: Precision immune engineering for the immune-privileged landscape of ocular malignancies

   Qamar Abuhassan, Kamel A. Saleh, S Renuka Jyothi +5

   МақолаOcular Oncology and TreatmentsBioimpacts20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.024071